Study on the Mechanism of Eating Disorder
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Anorexia Nervosa
- Sponsor
- Peking University
- Enrollment
- 750
- Locations
- 1
- Primary Endpoint
- The change of eating disorder behaviors and cognition
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Eating disorders (EDs) are severe chronic psychiatric disorders with a not fully understood etiopathogenesis. Previous studies have revealed some biological mechanisms of EDs. However, the etiology and maintenance mechanism of EDs, especially the neuro-mechanisms is still unknown. To explore the pathogenic mechanism and treatment biomarkers of EDs, we design this study. the multidimensional data including the clinicopathological features, neuroimaging data (functional and structural magnetic resonance imaging), electroencephalogram and inflammatory cytokines will be used to investigate the biomarkers for diagnosis and treatment effectiveness.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Anorexia nervosa
- •Anorexia nervosa according to Diagnostic and Statistical Manual of Mental Disorders (5th edition) (DSM-5);
- •Age: 13-35 (including 13 and 35)
- •BMI: 13-17.5kg/m\^2
- •The participants and/or their legal guardians ( for participants who are younger than 18-year-old) sign the informed consent form voluntarily and agree to participate in all visits and examinations as required by the trial protocol.
- •Do not take any psychiatric medications in past one month.
- •Bulimia nervosa
- •Bulimia nervosa according to Diagnostic and Statistical Manual of Mental Disorders (5th edition) (DSM-5);
- •Age: 13-35 years old (including 13 and 35)
- •The participants and/or their legal guardians ( for participants who are younger than 18-year-old) sign the informed consent form voluntarily and agree to participate in all visits and examinations as required by the trial protocol.
Exclusion Criteria
- •Patients who meet DSM-5 diagnostic criteria for other mental disorders: Major depressive disorder, anxiety, obsessive-compulsive disorder, personality disorder, mental retardation; drug and/or alcohol dependence;
- •Patients who receive repetitive Transcranial Magnetic Stimulation (rTMS) or modified electroconvulsive therapy (MECT) treatment in past six months.
- •Patients with severe suicidal tendencies or suicidal behavior
- •Pregnant or lactating women;
- •Patients with MRI contraindications;
- •Patients who are regarded as unsuitable by investigators for this clinical trial.
Outcomes
Primary Outcomes
The change of eating disorder behaviors and cognition
Time Frame: Day 0 to Day 56
The change of scores of Eating Disorder Examination Questionnaire (EDEQ) will be used to estimate the change of behaviors and cognition during treatment.The maximum score of EDEQ is 32.5 and the minium score is 0.
The change of severity of illness at 8 weeks
Time Frame: Day 0 to Day 56
The change of scores of Eating disorder Inventory (EDI) will be used to estimate the change of severity of illness. The scores of 8-week will be compared with those of baseline. The maximum of EDI is 396 and the minimum score is 0.
Secondary Outcomes
- The change of eating disorder behaviors and cognition(Day 0 to Day 28; Day 0 to Month 3; Day 0 to Month 6; Day 0 to Month 12)
- The change of severity of illness at early or later timepoints during treatment(Day 0 to Day 28; Day 0 to Month 3; Day 0 to Month 6; Day 0 to Month 12)